Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197866) titled 'An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy' on Sept. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Condition: Multiple System Atrophy

Intervention: Drug: TEV-56286

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: September 29, 2025

Target Sample Size: 200

To know more, visit https://clinicaltrials.gov/study/NCT07197866

Published by HT Digital Content Se...